Product Name

  • Name

    Voriconazole

  • EINECS 629-701-5
  • CAS No. 137234-62-9
  • Article Data35
  • CAS DataBase
  • Density 1.42 g/cm3
  • Solubility
  • Melting Point 127-130 °C
  • Formula C16H14F3N5O
  • Boiling Point 508.6 °C at 760 mmHg
  • Molecular Weight 349.315
  • Flash Point 261.4 °C
  • Transport Information
  • Appearance cyrstalline solid
  • Safety 26-36
  • Risk Codes 22-36/38
  • Molecular Structure Molecular Structure of 137234-62-9 (Voriconazole)
  • Hazard Symbols HarmfulXn
  • Synonyms 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-,(alphaR,betaS)-;DRG-0301;UK-109,496;UNII-JFU09I87TR;Vfend;VRC;
  • PSA 76.72000
  • LogP 2.17690

Synthetic route

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulfonate
188416-34-4, 137234-71-0

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (1R)-10-camphorsulfonate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane for 0.5h;92%
With sodium hydrogencarbonate In water; ethyl acetate90.47%
With sodium hydroxide In water at 45 - 55℃; for 2.5h; Product distribution / selectivity;87.22%
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol R-(-)-10-camphorsulfonate

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol R-(-)-10-camphorsulfonate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water pH=11 - 12;92%
voriconazole L-camphorsulfate

voriconazole L-camphorsulfate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane for 0.5h;92%
With sodium hydroxide In dichloromethane; water at 15 - 25℃; pH=10 - 11;
voriconazole L-camphor sulfonate

voriconazole L-camphor sulfonate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane for 0.5h;90.8%
With sodium hydroxide In dichloromethane; water pH=12.3; Product distribution / selectivity; Alkaline aqueous solution; Industry scale;72%
With sodium hydroxide In dichloromethane; water pH=11; Product distribution / selectivity; Alkaline aqueous solution;
C26H28F3N5O5S

C26H28F3N5O5S

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With 5%-palladium/activated carbon; hydrogen In ethanol under 760.051 Torr;86.3%
(2R,3S)-3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1 yl)butan-2-ol
188416-38-8

(2R,3S)-3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1 yl)butan-2-ol

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With palladium 10% on activated carbon; potassium formate In ethanol; water at 30℃; for 1h; Temperature; Reagent/catalyst; Inert atmosphere;84.9%
With palladium 10% on activated carbon; hydrogen; sodium acetate In water; toluene at -21 - 40℃; under 3750.38 Torr; for 22h;
(2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt
848469-32-9

(2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium carbonate In dichloromethane; water at 20℃; for 0.333333h; pH=~ 10; Product distribution / selectivity;76%
With sodium hydroxide In dichloromethane; water pH=11 - 12; Product distribution / selectivity;
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((1R,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1yl)methanesulfonate

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((1R,4R)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1yl)methanesulfonate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With water In ethanol at 32.5℃; Concentration; Solvent; Temperature;76%
2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butane-2-ol

2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butane-2-ol

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With [(1R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid In methanol; acetone for 2h; Reflux;43%
With (R)-10-camphorsulfonic acid In methanol; acetone at 0 - 5℃; Resolution of racemate;40.1%
Multi-step reaction with 2 steps
1: acetone; methanol / 15 h / -20 - 25 °C
2: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
Multi-step reaction with 2 steps
1: methanol; acetone / Reflux
2: sodium hydroxide / water; dichloromethane / pH 11
View Scheme
5-fluoro-4-vinylpyrimidine
1602485-93-7

5-fluoro-4-vinylpyrimidine

1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone
86404-63-9

1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With CuF(PPh3)3 methanol solvate; (R)-(−)-1-[(R)-2-(2′-diphenylphosphinophenyl)ferrocenyl]ethylbis(di-3,5-trifluoromethylphenyl)phosphine at 0℃; for 21.5h; Reagent/catalyst; Inert atmosphere;40%
3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
188416-35-5

3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Stage #1: 3-(6-chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol With 5%-palladium/activated carbon; hydrogen; sodium acetate In methanol at 25℃; under 760.051 Torr;
Stage #2: With [(1R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid In methanol; acetone for 2h; Reflux;
35%
Multi-step reaction with 3 steps
1.1: sodium acetate / ethyl acetate; water / 0.5 h / 25 - 30 °C
1.2: 25 - 30 °C / 3677.86 Torr
1.3: 0.5 h / 20 - 25 °C
2.1: acetone; methanol / 15 h / -20 - 25 °C
3.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
Multi-step reaction with 4 steps
1.1: hydrogen; sodium acetate / palladium 10% on activated carbon / ethyl acetate; water / 25 - 30 °C / 3677.86 Torr
1.2: 0.5 h / 20 - 25 °C
1.3: 12.5 h / 25 - 30 °C
2.1: sodium hydroxide / dichloromethane; water / 0.5 h / pH 9 - 12
3.1: acetone; methanol / 15 h / -20 - 25 °C
4.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
Multi-step reaction with 4 steps
1.1: hydrogen; sodium acetate; sodium carbonate / palladium 10% on activated carbon / ethyl acetate; water / 25 - 30 °C / 3677.86 Torr
1.2: 0.5 h / 20 - 25 °C
1.3: 10 - 25 °C
2.1: potassium carbonate / dichloromethane; water / 0.5 h / pH 8 - 10
3.1: acetone; methanol / 15 h / -20 - 25 °C
4.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
1,2,4-Triazole
288-88-0

1,2,4-Triazole

4-((S)-1-((R)-2-(2,4-difluorophenyl)oxirane-2-yl)ethyl)-5-fluoropyrimidine
1474024-68-4

4-((S)-1-((R)-2-(2,4-difluorophenyl)oxirane-2-yl)ethyl)-5-fluoropyrimidine

A

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol
1028563-65-6

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol

B

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
In ethanol at 80℃; for 18h; Inert atmosphere;A 27%
B n/a
C n/a
4-bromo-5-fluoro-pyrimidine
1003706-87-3

4-bromo-5-fluoro-pyrimidine

(3S)-2-(2,4-difluorophenyl)-3-methyl-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

(3S)-2-(2,4-difluorophenyl)-3-methyl-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
In tetrahydrofuran at -70 - 30℃; for 25h; Temperature; Inert atmosphere;26.3%
(3S)-2-(2,4-difluorophenyl)-3-methyl-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

(3S)-2-(2,4-difluorophenyl)-3-methyl-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

2,4-dichloro-5-fluoropyrimidine
347418-42-2

2,4-dichloro-5-fluoropyrimidine

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
In tetrahydrofuran at -70 - 30℃; for 25h; Temperature; Inert atmosphere;20.7%
(2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

A

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

B

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With hydrogen; sodium acetate; palladium on activated charcoal In ethanol at 20℃;
2-fluoro-3-oxopentanoic acid ethyl ester
759-67-1

2-fluoro-3-oxopentanoic acid ethyl ester

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1) MeONa, MeOH
2: POCl3 / Heating
3: LDA / tetrahydrofuran
4: H2, AcONa / Pd/C / ethanol / 20 °C
View Scheme
6-Ethyl-5-fluoropyrimidin-4(3H)-one
137234-87-8

6-Ethyl-5-fluoropyrimidin-4(3H)-one

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: POCl3 / Heating
2: LDA / tetrahydrofuran
3: H2, AcONa / Pd/C / ethanol / 20 °C
View Scheme
4-chloro-5-fluoro-6-ethylpyrimidine
137234-74-3

4-chloro-5-fluoro-6-ethylpyrimidine

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: LDA / tetrahydrofuran
2: H2, AcONa / Pd/C / ethanol / 20 °C
View Scheme
Multi-step reaction with 4 steps
1.1: diisopropylamine; n-butyllithium / n-heptane; hexane; tetrahydrofuran / 0.25 h / -80 - -70 °C / Inert atmosphere
1.2: 2 h / -80 - -55 °C
1.3: -70 - -10 °C
2.1: sodium acetate / ethyl acetate; water / 0.5 h / 25 - 30 °C
2.2: 25 - 30 °C / 3677.86 Torr
2.3: 0.5 h / 20 - 25 °C
3.1: acetone; methanol / 15 h / -20 - 25 °C
4.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
Multi-step reaction with 5 steps
1.1: diisopropylamine; n-butyllithium / n-heptane; hexane; tetrahydrofuran / 0.25 h / -80 - -70 °C / Inert atmosphere
1.2: 2 h / -80 - -55 °C
1.3: -70 - -10 °C
2.1: hydrogen; sodium acetate / palladium 10% on activated carbon / ethyl acetate; water / 25 - 30 °C / 3677.86 Torr
2.2: 0.5 h / 20 - 25 °C
2.3: 12.5 h / 25 - 30 °C
3.1: sodium hydroxide / dichloromethane; water / 0.5 h / pH 9 - 12
4.1: acetone; methanol / 15 h / -20 - 25 °C
5.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
2-(2,4difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol-R(-)-10-camphor sulphonate
321589-01-9

2-(2,4difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)-butan-2-ol-R(-)-10-camphor sulphonate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water at 25 - 35℃; pH=11 - 12; Alkaline conditions;
1-(4-chloro-5-fluoropyrimidin-6-yl)bromoethane
188416-28-6

1-(4-chloro-5-fluoropyrimidin-6-yl)bromoethane

1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone
86404-63-9

1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone

A

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

B

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Stage #1: 1-(4-chloro-5-fluoropyrimidin-6-yl)bromoethane; 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazolyl)ethanone With zinc(II) chloride; zinc In tetrahydrofuran at -5 - 5℃; for 1h;
Stage #2: With ammonium formate; zinc In methanol at 20℃; for 16h;
Stage #3: Product distribution / selectivity; Heating / reflux;
3-(6-chloro-5-fluoro-4-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride

3-(6-chloro-5-fluoro-4-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride

A

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

B

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With ammonium formate; zinc In methanol Product distribution / selectivity;
C10H16O4S*C16H14F3N5O

C10H16O4S*C16H14F3N5O

A

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

B

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; ethyl acetate at 20 - 25℃;
2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
182230-43-9

2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Stage #1: 2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol With (R)-10-camphorsulfonic acid In methanol; acetone at 25 - 60℃; for 2h;
Stage #2: With sodium hydroxide In dichloromethane; water; isopropyl alcohol at 20 - 30℃; pH=12 - 13; Product distribution / selectivity;
With (1S)-10-camphorsulfonic acid In methanol; acetone at 20 - 30℃; for 3.5h; Reflux;
Multi-step reaction with 2 steps
1: sodium hydroxide / water / 3 h / 45 °C
2: camphor-10-sulfonic acid / methanol; acetone
View Scheme
C6H5FN2O
1289559-75-6

C6H5FN2O

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sodium tetrahydroborate / ethanol / 5 h
2.1: triethylamine / dmap / dichloromethane / 20 - 30 °C
3.1: zinc; zinc(II) chloride / tetrahydrofuran / 0 - 30 °C
4.1: (R)-10-camphorsulfonic acid / acetone; methanol / 2 h / 25 - 60 °C
4.2: 20 - 30 °C / pH 12 - 13
View Scheme
1-(2,6-dichloro-5-fluoropyrimidin-4-yl)ethanone
1289559-65-4

1-(2,6-dichloro-5-fluoropyrimidin-4-yl)ethanone

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: hydrogen; sodium acetate / palladium on activated carbon / ethanol / 25 °C
2.1: sodium tetrahydroborate / ethanol / 5 h
3.1: triethylamine / dmap / dichloromethane / 20 - 30 °C
4.1: zinc; zinc(II) chloride / tetrahydrofuran / 0 - 30 °C
5.1: (R)-10-camphorsulfonic acid / acetone; methanol / 2 h / 25 - 60 °C
5.2: 20 - 30 °C / pH 12 - 13
View Scheme
1-(5-fluoropyrimidin-4-yl)ethanol
1289559-66-5

1-(5-fluoropyrimidin-4-yl)ethanol

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: triethylamine / dmap / dichloromethane / 20 - 30 °C
2.1: zinc; zinc(II) chloride / tetrahydrofuran / 0 - 30 °C
3.1: (R)-10-camphorsulfonic acid / acetone; methanol / 2 h / 25 - 60 °C
3.2: 20 - 30 °C / pH 12 - 13
View Scheme
2-chloro-1-(2,4-dichlorophenyl)ethanone
51336-94-8

2-chloro-1-(2,4-dichlorophenyl)ethanone

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: potassium carbonate / tetrahydrofuran / 7 h / 20 °C
2: lead; zinc; iodine / tetrahydrofuran / -15 - 20 °C / Inert atmosphere
3: ammonium formate / palladium on carbon / toluene / 3 h / 80 °C
4: acetone; methanol / 1 h / Reflux
5: sodium hydrogencarbonate / dichloromethane / 0.5 h
View Scheme
Multi-step reaction with 5 steps
1: potassium carbonate / tetrahydrofuran / 7 h / 20 °C
2: lead; zinc; iodine / tetrahydrofuran / 2 h / -15 - -10 °C / Inert atmosphere
3: ammonium formate / 10% palladium on charcoal / toluene / 3 h / 80 °C
4: acetone; methanol / 1 h / Reflux
5: sodium hydrogencarbonate / dichloromethane / 0.5 h
View Scheme
6-ethyl-5-fluoro-4-hydroxypyrimidine
137234-87-8

6-ethyl-5-fluoro-4-hydroxypyrimidine

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: triethylamine / dichloromethane / 5 h / 20 °C
2: 2,2'-azobis(isobutyronitrile); N-Bromosuccinimide / dichloromethane / 12 h / 45 - 50 °C
3: lead; zinc; iodine / tetrahydrofuran / -15 - 20 °C / Inert atmosphere
4: ammonium formate / palladium on carbon / toluene / 3 h / 80 °C
5: acetone; methanol / 1 h / Reflux
6: sodium hydrogencarbonate / dichloromethane / 0.5 h
View Scheme
Multi-step reaction with 5 steps
1.1: triethylamine / dichloromethane / 5 - 10 °C
1.2: 8 h / 10 - 55 °C / Reflux
1.3: 0.5 h / 15 - 20 °C
2.1: diisopropylamine; n-butyllithium / n-heptane; hexane; tetrahydrofuran / 0.25 h / -80 - -70 °C / Inert atmosphere
2.2: 2 h / -80 - -55 °C
2.3: -70 - -10 °C
3.1: sodium acetate / ethyl acetate; water / 0.5 h / 25 - 30 °C
3.2: 25 - 30 °C / 3677.86 Torr
3.3: 0.5 h / 20 - 25 °C
4.1: acetone; methanol / 15 h / -20 - 25 °C
5.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
Multi-step reaction with 6 steps
1.1: triethylamine / dichloromethane / 5 - 10 °C
1.2: 8 h / 10 - 55 °C / Reflux
1.3: 0.5 h / 15 - 20 °C
2.1: diisopropylamine; n-butyllithium / n-heptane; hexane; tetrahydrofuran / 0.25 h / -80 - -70 °C / Inert atmosphere
2.2: 2 h / -80 - -55 °C
2.3: -70 - -10 °C
3.1: hydrogen; sodium acetate / palladium 10% on activated carbon / ethyl acetate; water / 25 - 30 °C / 3677.86 Torr
3.2: 0.5 h / 20 - 25 °C
3.3: 12.5 h / 25 - 30 °C
4.1: sodium hydroxide / dichloromethane; water / 0.5 h / pH 9 - 12
5.1: acetone; methanol / 15 h / -20 - 25 °C
6.1: sodium hydroxide / dichloromethane; water / 0.25 h / pH 11 - 14
View Scheme
6-ethyl-5-fluoropyrimidin-4-yl methanesulfonate
1237496-99-9

6-ethyl-5-fluoropyrimidin-4-yl methanesulfonate

voriconazole
137234-62-9

voriconazole

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 2,2'-azobis(isobutyronitrile); N-Bromosuccinimide / dichloromethane / 12 h / 45 - 50 °C
2: lead; zinc; iodine / tetrahydrofuran / -15 - 20 °C / Inert atmosphere
3: ammonium formate / palladium on carbon / toluene / 3 h / 80 °C
4: acetone; methanol / 1 h / Reflux
5: sodium hydrogencarbonate / dichloromethane / 0.5 h
View Scheme
Multi-step reaction with 5 steps
1: 2,2'-azobis(isobutyronitrile); N-Bromosuccinimide / dichloromethane / 12 h / 45 - 50 °C
2: lead; zinc; iodine / tetrahydrofuran / 2 h / -15 - -10 °C / Inert atmosphere
3: ammonium formate / 10% palladium on charcoal / toluene / 3 h / 80 °C
4: acetone; methanol / 1 h / Reflux
5: sodium hydrogencarbonate / dichloromethane / 0.5 h
View Scheme
4-((1,3-bis(octanoyloxy)propan-2-yl)oxy)-4-oxobutanoic acid
150994-82-4

4-((1,3-bis(octanoyloxy)propan-2-yl)oxy)-4-oxobutanoic acid

voriconazole
137234-62-9

voriconazole

4-((1,3-bis(octanoyloxy)propan-2-yl)oxy)-4-oxobutanoate 4-((2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-5-fluoropyrimidin-1-ium

4-((1,3-bis(octanoyloxy)propan-2-yl)oxy)-4-oxobutanoate 4-((2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-5-fluoropyrimidin-1-ium

Conditions
ConditionsYield
In acetonitrile at 50℃; for 6h;100%
(2E)-4-((1,3-bis(dodecanoyloxy)propan-2-yl)oxy)-4-oxobut-2-enoic acid

(2E)-4-((1,3-bis(dodecanoyloxy)propan-2-yl)oxy)-4-oxobut-2-enoic acid

voriconazole
137234-62-9

voriconazole

(2E)-4-((1,3-bis(dodecanoyloxy)propan-2-yl)oxy)-4-oxobut-2-enoate 4-((2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-5-fluoropyrimidin-1-ium

(2E)-4-((1,3-bis(dodecanoyloxy)propan-2-yl)oxy)-4-oxobut-2-enoate 4-((2S,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)-5-fluoropyrimidin-1-ium

Conditions
ConditionsYield
In acetonitrile at 50℃; for 3h;100%
voriconazole
137234-62-9

voriconazole

voriconazole hydrochloride

voriconazole hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In water at 20℃; for 1h;100%
(2-chloro-6-fluorophenyl)methanol
56456-50-9

(2-chloro-6-fluorophenyl)methanol

voriconazole
137234-62-9

voriconazole

Bis(2-chloro-6-fluorobenzyl) (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butyl phosphate
194798-93-1

Bis(2-chloro-6-fluorobenzyl) (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butyl phosphate

Conditions
ConditionsYield
With 1-methyl-1H-imidazole; anhydrous phosphorus trichloride; dihydrogen peroxide In dichloromethane; tert-butyl methyl ether; water88%
voriconazole
137234-62-9

voriconazole

C16H13F3N6O3
1620283-07-9

C16H13F3N6O3

Conditions
ConditionsYield
With sulfuric acid; nitric acid at 20℃; for 3h;88%
With sulfuric acid; nitric acid at 0 - 20℃; for 3h;77%
C9H16ClNO5

C9H16ClNO5

voriconazole
137234-62-9

voriconazole

C20H22F3N6O4(1+)*I(1-)

C20H22F3N6O4(1+)*I(1-)

Conditions
ConditionsYield
Stage #1: C9H16ClNO5; voriconazole With potassium iodide In acetonitrile for 15h; Reflux;
Stage #2: With hydrogenchloride; water In methanol at 50 - 55℃; for 20h;
Stage #3: In methanol; tert-butyl methyl ether at 10 - 65℃; for 18h;
87%
voriconazole
137234-62-9

voriconazole

C16H14F3N5O*HNO3

C16H14F3N5O*HNO3

Conditions
ConditionsYield
With nitric acid In methanol; water86.62%
chloromethyl 2-methoxyethyl carbonate
432037-32-6

chloromethyl 2-methoxyethyl carbonate

voriconazole
137234-62-9

voriconazole

C21H23F3N5O5(1+)*Cl(1-)

C21H23F3N5O5(1+)*Cl(1-)

Conditions
ConditionsYield
In acetonitrile for 10h; Reflux;85%
chloromethyl 2-methoxyethyl carbonate
432037-32-6

chloromethyl 2-methoxyethyl carbonate

voriconazole
137234-62-9

voriconazole

C21H23F3N5O5(1+)*Cl(1-)

C21H23F3N5O5(1+)*Cl(1-)

Conditions
ConditionsYield
In acetonitrile for 12h; Reflux;80%
chloromethyl 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethyl carbonate
431894-46-1

chloromethyl 2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethyl carbonate

voriconazole
137234-62-9

voriconazole

C38H56F3N5O15(2+)*2Cl(1-)

C38H56F3N5O15(2+)*2Cl(1-)

Conditions
ConditionsYield
In acetonitrile for 14h; Reflux;79%
voriconazole
137234-62-9

voriconazole

voriconazole hydrochloride

voriconazole hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol; water78.62%
isobutyric Acid
79-31-2

isobutyric Acid

voriconazole
137234-62-9

voriconazole

A

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-6-isopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-6-isopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

B

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-2,6-diisopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-2,6-diisopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

Conditions
ConditionsYield
With bis-[(trifluoroacetoxy)iodo]benzene; 9-mesityl-10-methylacridinium ion In acetonitrile at 20℃; Irradiation;A 77%
B 11%
trifluoroacetic acid
76-05-1

trifluoroacetic acid

voriconazole
137234-62-9

voriconazole

(2R,3S)-2-(5-bromo-2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol trifluoroacetic acid

(2R,3S)-2-(5-bromo-2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol trifluoroacetic acid

Conditions
ConditionsYield
With N-Bromosuccinimide for 16h; Inert atmosphere;73%
potassium trifluoro(isopropenyl)borate(1-)

potassium trifluoro(isopropenyl)borate(1-)

voriconazole
137234-62-9

voriconazole

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-6-isopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-6-isopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

Conditions
ConditionsYield
With N,N,N,N-tetraethylammonium tetrafluoroborate; trifluoroacetic acid; 9-(2-mesityl)-10-methylacridinium perchlorate In water; acetonitrile at 20℃; for 10h; Inert atmosphere; Schlenk technique; Irradiation; regioselective reaction;72%
C9H17ClN2O4

C9H17ClN2O4

voriconazole
137234-62-9

voriconazole

C20H23F3N7O3(1+)*I(1-)

C20H23F3N7O3(1+)*I(1-)

Conditions
ConditionsYield
Stage #1: C9H17ClN2O4; voriconazole With potassium iodide In acetonitrile for 15h; Reflux;
Stage #2: With hydrogenchloride; water In methanol at 50 - 55℃; for 20h;
Stage #3: In methanol; tert-butyl methyl ether at 10 - 65℃; for 15h;
70%
(1S)-10-camphorsulfonic acid
3144-16-9

(1S)-10-camphorsulfonic acid

voriconazole
137234-62-9

voriconazole

(2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt
848469-32-9

(2R,3S)-2-(2,4-diflurophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1yl)butan-2-ol R-(-)-10-camphor sulphonate salt

Conditions
ConditionsYield
In methanol; acetone at 30 - 50℃; for 1.33333h; Heating / reflux;65%
C23H43ClN4O8

C23H43ClN4O8

voriconazole
137234-62-9

voriconazole

C24H33F3N9O3(1+)*I(1-)

C24H33F3N9O3(1+)*I(1-)

Conditions
ConditionsYield
Stage #1: C23H43ClN4O8; voriconazole With potassium iodide In acetonitrile for 15h; Reflux;
Stage #2: With hydrogenchloride; water In methanol at 50 - 55℃; for 20h;
Stage #3: In methanol; tert-butyl methyl ether at 10 - 65℃; for 18h;
65%
chloromethyl (2-methoxyethyl)carbamate
1402915-09-6

chloromethyl (2-methoxyethyl)carbamate

voriconazole
137234-62-9

voriconazole

C21H24F3N6O4(1+)*I(1-)

C21H24F3N6O4(1+)*I(1-)

Conditions
ConditionsYield
Stage #1: chloromethyl (2-methoxyethyl)carbamate; voriconazole With potassium iodide In acetonitrile for 15h; Reflux;
Stage #2: In methanol; tert-butyl methyl ether at 10 - 65℃; for 20h;
63%
voriconazole
137234-62-9

voriconazole

Cyclohexanecarboxylic acid
98-89-5

Cyclohexanecarboxylic acid

(2R,3S)-3-(6-cyclohexyl-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S)-3-(6-cyclohexyl-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

Conditions
ConditionsYield
With hydrogenchloride; cerium(III) chloride heptahydrate; tetrabutyl-ammonium chloride In 2,2,2-trifluoroethanol; water for 17h; Schlenk technique; Inert atmosphere; Electrochemical reaction; Irradiation;60%
potassium trifluoro(isopropenyl)borate(1-)

potassium trifluoro(isopropenyl)borate(1-)

trifluoroacetic acid
76-05-1

trifluoroacetic acid

voriconazole
137234-62-9

voriconazole

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-6-isopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol trifluoroacetic acid

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-6-isopropylpyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol trifluoroacetic acid

Conditions
ConditionsYield
Stage #1: potassium trifluoro(isopropenyl)borate(1-); voriconazole With manganese triacetate; acetic acid In water at 50℃; for 18h; Inert atmosphere;
Stage #2: trifluoroacetic acid In water; acetonitrile Inert atmosphere;
58%
silver perchlorate

silver perchlorate

voriconazole
137234-62-9

voriconazole

Ag(1+)*ClO4(1-)*2C16H14F3N5O

Ag(1+)*ClO4(1-)*2C16H14F3N5O

Conditions
ConditionsYield
In ethanol; water58%

Voriconazole Chemical Properties

Molecular structure of Voriconazole (CAS NO.137234-62-9) is:

Product Name: Voriconazole
CAS Registry Number: 137234-62-9
IUPAC Name:  (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
Molecular Weight: 349.31047 [g/mol]
Molecular Formula: C16H14F3N5O
XLogP3-AA: 1.5
H-Bond Donor: 1
H-Bond Acceptor: 8
Melting Point: 127-130 °C
Surface Tension: 45.1 dyne/cm
Density: 1.42 g/cm3
Flash Point: 261.4 °C
Enthalpy of Vaporization: 82.02 kJ/mol
Boiling Point: 508.6 °C at 760 mmHg
Vapour Pressure: 3.63E-11 mmHg at 25°C 
Product Categories: API; Antifungal (Systemic); Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals

Voriconazole History

   London, UK, 16 December 2008 - The effectiveness of voriconazole in combating fungal infections has been confirmed by a new study to be featured in the International Journal of Antimicrobial Agents ,published by Elsevier.

Voriconazole Uses

 Voriconazole (CAS NO.137234-62-9) is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.

Voriconazole Toxicity Data With Reference

    The most common side effects associated with voriconazole(137234-62-9) include transient visual disturbances, fever, rash, vomiting, nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain, and respiratory disorder.This medication may also cause the skin to peel easily. It is best to apply lotion and/or coconut oil to help with this side effect.

Voriconazole Safety Profile

Safty information about Voriconazole (CAS NO.137234-62-9) is:
Hazard Codes: HarmfulXn
Risk Statements: 22-36/38 
R22:Harmful if swallowed. 
R36/38:Irritating to eyes and skin.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36:Wear suitable protective clothing.

Voriconazole Specification

 Voriconazole , its cas register number is 137234-62-9. It also can be called Voriconazole [USAN:INN:BAN] ; (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol ; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-,(alphaR,betaS)- ; DRG-0301 ; UK-109,496 ; UNII-JFU09I87TR ; VRC ; Vfend ; Voriconazole ; (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol ; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))- . It is a cyrstalline solid.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View